Latest News about Hoth Therapeutics
Recent news which mentions Hoth Therapeutics
Hoth Therapeutics Reports Being Ready For 2022 As It Anticipates Major Milestones In Drug Pipeline
February 08, 2022
Tickers
HOTH
From Benzinga
Hoth Therapeutics Reports Its Milestones In Its Drug Development In 2021
February 03, 2022
Tickers
HOTH
From Benzinga
Hoth Therapeutics Reports Being Set To Begin Phase 2 Study On First-Of-Its-Kind Skin Toxicity Ointment For Cancer Patients
February 01, 2022
From Benzinga
Hoth's Management Team And Scientific Advisory Board Report Wrapping Up A Busy 2021 Of Clinical Research
January 27, 2022
From Benzinga
Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
January 04, 2022
Tickers
HOTH
From Benzinga
Hoth Therapeutics Reports Orphan Designation Application to Treat Mastocytosis, To Receive Exclusive Rights and Cost Benefits on Approval
December 21, 2021
From Benzinga
Hoth Therapeutics Reports Finishing Up a Busy Year of Research Across its Portfolio of Drug Candidates
December 20, 2021
Tickers
HOTH
From Benzinga